Two spine companies launched public offerings since Feb. 26.
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering. The company listed 5,175,000 units at 58 cents each.
Bone Biologics, a company focused on spine fusion products, announced a $2 million public offering. The public offering includes 781,251 shares of its common stock for $2.56 per share.